Eisai
4523.T
#2012
Rank
C$11.44 B
Marketcap
$40.61
Share price
0.12%
Change (1 day)
-39.20%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : C$1.50 Billion

According to Eisai's latest financial reports the company's total debt is C$1.50 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-03-31C$1.28 B31.88%
2022-03-31C$0.97 B-5.62%
2021-03-31C$1.02 B-12.86%
2020-03-31C$1.18 B-29.34%
2019-03-31C$1.67 B-20.56%
2018-03-31C$2.10 B-17.42%
2017-03-31C$2.54 B8.3%
2016-03-31C$2.35 B-5.69%
2015-03-31C$2.49 B-6.11%
2014-03-31C$2.65 B-21.64%
2013-03-31C$3.38 B-18.56%
2012-03-31C$4.16 B-6.25%
2011-03-31C$4.43 B-0.27%
2010-03-31C$4.45 B-17.24%
2009-03-31C$5.37 B26.55%
2008-03-31C$4.24 B183063.26%
2007-03-31C$2.31 M-43.34%
2006-03-31C$4.09 M-56.52%
2005-03-31C$9.41 M292.28%
2004-03-31C$2.4 M451%
2003-03-31C$0.43 M-99.44%
2002-03-31C$78.22 M-20.71%
2001-03-31C$98.65 M-61.38%
2000-03-31C$0.25 B